The novel cardiotonic agent EMD-57033 enhances cardiomyocyte contractility with greater energetic efficiency than isoproterenol or elevated calcium, likely via calcium sensitization.
No takes yet. Share an insight, caveat, or question.
Supports preclinical development of energy-efficient inotropes; leaves open clinical translation in heart failure.
Pöpping et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: